Well, that's the issue; for the imminent TRW-dividend that were protected from dilution by the ECAB-agreement
I get that you are annoyed by my furious bashing, but at least someone liked my point that the H2/18-dividend could/should be viewed as a semi-annual dividend and not an annual one (which I've also have pointed out on two other forums, which might have increased the support for the PPS).
I agree with the first part - it was very wise to also declare the dividend for 2019. However, there is no chance that institutional investors will join before Solomon has retired as CEO (at least I can't see how it is better to dilute with a 3$/share hit to book value than to take a loss and take a 3cents/share hit - not accurate numbers, but you get the drift if you read my other post)
20$ is not going to happen anytime soon (without TRW-financing at least). EPS of 17 cents/shares (with the OLD OS) needs a P/E of 29; OTC will still have the china-bias-discount and it is highly unlikely that Merkur will give SIAF a P/E of 29
Agreed. Althought the never-ending delay of the TRW-dividend might mess up things somewhat (more than it already has that is)
And when are we gettting the loan? You have been saying we are close for the last 6 months. But the impression from the CC is that we are no where near close at the moment